| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/10/2004 | CA2517310A1 Stabilized protein-containing formulations_comprising a poloxamer |
| 09/10/2004 | CA2517289A1 Stable pharmaceutical composition of rabeprazole and processes for their preparation |
| 09/10/2004 | CA2516459A1 Pharmaceutical compositions for nasal delivery |
| 09/10/2004 | CA2516399A1 Pharmaceutical compositions of safingol and methods of using the same |
| 09/10/2004 | CA2513836A1 Hypoallergenic der p1 and der p3 proteins from dermatographoides pteronyssinus |
| 09/10/2004 | CA2507527A1 Glycosolated enkephalin agents |
| 09/09/2004 | US20040176750 Implantable reservoir and system for delivery of a therapeutic agent |
| 09/09/2004 | US20040176749 Insert for the treatment of dry eye |
| 09/09/2004 | US20040176748 Device, method and kit for preventing sexually transmitted disease, generating penile erection and effecting birth control by injecting beneficial agents deep into the male urethra canal prior to sexual intercourse |
| 09/09/2004 | US20040176684 Endoscope pretest capsule |
| 09/09/2004 | US20040176667 Method and system for medical device connectivity |
| 09/09/2004 | US20040176581 Method to produce a solid form of heparin |
| 09/09/2004 | US20040176535 Polymeric composition based on PVA |
| 09/09/2004 | US20040176476 Pharmaceutical composition |
| 09/09/2004 | US20040176473 Methods for delivering compounds into a cell |
| 09/09/2004 | US20040176465 Solid compositions containing fluoxetine and a coating |
| 09/09/2004 | US20040176463 Immediate release formulation of n-(2-propylpentanoyl)glycinamide |
| 09/09/2004 | US20040176439 coadministration of agent which exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide), and an oral bioavailability-enhancing agent (e.g., cyclosporin A, cyclosporin D, cyclosporin F) |
| 09/09/2004 | US20040176419 particularly chronic obstructive pulmonary disease (COPD), asthma or a related pulmonary disease such as chronic bronchitis or allergic rhinitis |
| 09/09/2004 | US20040176402 Controlled-release compositions containing opioid agonist and antagonist |
| 09/09/2004 | US20040176391 prophylaxis against a pulmonary fungal infection; delivering from 5 mg to 10 mg of amphotericin B when aerosolized |
| 09/09/2004 | US20040176359 Intranasal Benzodiazepine compositions |
| 09/09/2004 | US20040176357 Stable, amorphous , lyophilized, parenteral injections comprising olanzapine, solubilizer and stabilizer; bipolar, psychological and neurodegenerative disorders; anxiolytic agents;schizophrenia |
| 09/09/2004 | US20040176353 Derivatives of pyrimido[6,1-a]isoquinolin-4-one |
| 09/09/2004 | US20040176352 Chronotherapeutic diltiazem formulations and the administration thereof |
| 09/09/2004 | US20040176342 Fluticasone lotion having improved vasoconstrictor activity |
| 09/09/2004 | US20040176341 Injectable sustained release delivery devices |
| 09/09/2004 | US20040176338 Pharmaceutical compositions based on anticholinergics and corticosteroids |
| 09/09/2004 | US20040176328 Encapsulated bioactive bisphosphonate such as alendronate including mono- or diglyceride of caproic or capric acid enhancer or surfactant comprising ethylene oxide-propylene oxide block copolymer |
| 09/09/2004 | US20040176321 9-Fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid derivatives; basic amino acid or cyclodextrin solubilizer; microbiocide injections |
| 09/09/2004 | US20040176319 Cellular uptake of bioactive agents |
| 09/09/2004 | US20040176318 Pretreating with lipophilic substituted saccharide |
| 09/09/2004 | US20040176312 Treatment of ungual and subungual diseases |
| 09/09/2004 | US20040175795 Glial derived neurotrophic factor |
| 09/09/2004 | US20040175731 Preparing transgenic microorganism comprising modified intercellular adhesion (ica) locus and which generates cell surface proteins with altered poly-N-acetyl glucosamine (PNAG) side chain profile for use in vaccine development; bactericides |
| 09/09/2004 | US20040175703 to be administered by inhalation, infusion, injection, or orally relates to double-stranded ribonucleic acid (dsRNA), and its use in mediating RNA interference in vitro and in vivo; genetic engineering |
| 09/09/2004 | US20040175686 Process for producing an artificial bone model and an artificial bone model produced by the process |
| 09/09/2004 | US20040175443 Food supplement for increasing lean mass and strength |
| 09/09/2004 | US20040175442 Food supplement for increasing lean mass and strength |
| 09/09/2004 | US20040175437 preventing and treating certain inflammatory diseases, degenerative diseases and viral diseases in mammals |
| 09/09/2004 | US20040175435 preservative that do not become complexed with, or to a lesser degree than does benzalkonium chloride, cyclodextrin and are not rendered ineffective; chlorite or sorbic acid preservative |
| 09/09/2004 | US20040175433 using a viscous rather than a liquid footbath performs much better in preventing and combating hoof diseases; active ingredient and a colloid former |
| 09/09/2004 | US20040175429 Biodegradable microparticles that stabilize and control the release of proteins |
| 09/09/2004 | US20040175428 Controlled release by extrusion of solid amorphous dispersions of drugs |
| 09/09/2004 | US20040175427 Omeprazole formulation |
| 09/09/2004 | US20040175426 in free-base or protonated acid form; for treating glaucoma; providing high concentrations of active compounds to the locus where their activity is desired |
| 09/09/2004 | US20040175425 Systems, methods and apparatuses for manufacturing dosage forms |
| 09/09/2004 | US20040175424 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same |
| 09/09/2004 | US20040175423 hydroxypropyl methyl cellulose is not part of the granule composition but is compressed with the granules into the final controlled release tablet |
| 09/09/2004 | US20040175422 excellent storage stability and little tendency to change the release rate of the pharmacologically active substance even after long-term storage; matrix comprising low-melting-point substance and pH-independent water-insoluble polymer |
| 09/09/2004 | US20040175421 improved glyburide dissolvability and bioavailability similar to single form dosage; glyburide in the form of fine dispersed particles with diameters of less than 45 mu m or, preferably, less than 35 mu m |
| 09/09/2004 | US20040175420 at least one non-ionic or zwitterionic surfactant and dispersant; improves the efficacy and/or potency of the lipase inhibitor; inter-subject variability in efficacy and/or potency is reduced, as well as the frequency and intensity of side effects |
| 09/09/2004 | US20040175419 controlling crystallization parameters of active ingredient to achieve increased compactability; compacting the active ingredient into a tablet |
| 09/09/2004 | US20040175418 Teste masking pharmaceutical composition |
| 09/09/2004 | US20040175417 Amphotericin B liposome preparation |
| 09/09/2004 | US20040175416 Pharmaceutical composition for transdermal or transmucous administration |
| 09/09/2004 | US20040175415 Formulations and methods of delivery of intact tocopheryl succinate to humans |
| 09/09/2004 | US20040175410 Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors |
| 09/09/2004 | US20040175406 Implantable or insertable medical devices containing miscible polymer blends for controlled delivery of a therapeutic agent |
| 09/09/2004 | US20040175404 Plurality of moisture sensitive microspheres formed of a matrix and encapsulated fragrance comprising menthol; fragrance burst and release upon contact with moisture; time-release agents |
| 09/09/2004 | US20040175402 Formulation |
| 09/09/2004 | US20040175401 Drug delivery to the dermis mammal to improve systemic absorption |
| 09/09/2004 | US20040175371 Introducing a biological material into a patient |
| 09/09/2004 | US20040175363 Defective recombinant adenovirus; treatment of neurodenerative, cardiovascular, brain, genetic, nervous system and respiratory system disorders; Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), atherosclerosis, and/or trisomy 2; adult respiratory distress syndrome; anticarcinogenic agents |
| 09/09/2004 | US20040175361 Modulator of desmosomal cadherin-mediated cell adhesion using a Trp(tryptophan)-containing cell adhesion recognition sequence; anticarcinogenic, antitumor, and antimetastasis agents |
| 09/09/2004 | US20040175353 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damage cutaneous tissue |
| 09/09/2004 | US20040175348 formed by spray-drying a solution of an edible organic acid wherein chitosan is dissolved; storage stability |
| 09/09/2004 | US20040175335 Sunscreen composition |
| 09/09/2004 | US20040175331 controlling a dissolution rate of a bioactive agent |
| 09/09/2004 | US20040175328 free-flowing, smooth, spherical microparticles of water-soluble material, mass median particle size of 1 to 10 mu m; inhalants |
| 09/09/2004 | US20040173923 Homogenised product for implants and microparticles |
| 09/09/2004 | US20040173696 solubilizing one or more poorly water-soluble drug candidates in an appropriate solvent |
| 09/09/2004 | US20040173224 Nicotine salts having improved taste, process for their preparation and their use |
| 09/09/2004 | US20040173147 Application of a bioactive agent to a delivery substrate |
| 09/09/2004 | US20040173146 Application of a bioactive agent to a delivery substrate |
| 09/09/2004 | DE19542785B4 Leerkapsel zur Aufnahme von Arzneimitteln, Nahrungsmitteln und dergleichen Empty capsule for inclusion of pharmaceuticals, food, etc. |
| 09/09/2004 | DE10308852A1 Use of spasmolytics in liposomes and/or cerasomes in the production of agents for use in countering muscular spasms or as anti-wrinkle agents |
| 09/09/2004 | DE10308774A1 Surfactant-free but diol-containing pharmaceutical or cosmetic formulations especially for use in soft gelatin capsules comprise a stable solution of an aqueous phase in an oil phase |
| 09/09/2004 | DE10304988A1 Transdermales Therapeutisches System mit verbessertem Hautklebeverhalten The transdermal therapeutic system with improved skin adhesive behavior |
| 09/09/2004 | DE10107663B4 Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung Testosterone-containing transdermal therapeutic system, process for its preparation and its use |
| 09/09/2004 | DE10004790B4 Method for producing sewn or embroidered three-dimensional textile structure utilized for e.g. table cloth, involves connecting points on lattice structure with threads to form thread arrangement under which lattice structure is not visible |
| 09/08/2004 | EP1454944A1 Polymeric composition based on polyvinyl alcohol |
| 09/08/2004 | EP1454928A1 PROCESS FOR PRODUCTION OF WATER−SOLUBLE (METH)ACRYLIC POLYMERS, WATER−SOLUBLE (METH)ACRYLIC POLYMERS, AND USE THEREOF |
| 09/08/2004 | EP1454893A1 Illudin analogs useful as antitumor agents |
| 09/08/2004 | EP1454640A2 Formulations of hyaluronic acid for delivery of osteogenic proteins |
| 09/08/2004 | EP1454636A1 Sterilization of glucocorticoid drug particles for pulmonary delivery |
| 09/08/2004 | EP1454635A1 Tasteless, directly compressible, fast-dissolving complexes and pharmaceutical formulations thereof |
| 09/08/2004 | EP1454634A1 Preparation compositions containing acid-unstable physiologically acitve compounds and process for producing the same |
| 09/08/2004 | EP1454631A1 Oral insulin composition and methods of making and using thereof |
| 09/08/2004 | EP1454630A1 Long acting injectable insulin composition and methods of making and using thereof |
| 09/08/2004 | EP1454623A1 Pad with a gel layer having cosmetic or therapeutic activity |
| 09/08/2004 | EP1454610A1 Cosmetic and/or pharmaceutical compositions comprising microencapsulated plant extracts |
| 09/08/2004 | EP1454534A1 Microcapsules and oral compositions containing the same |
| 09/08/2004 | EP1454533A1 Stimulation of saliva generation |
| 09/08/2004 | EP1453949A2 Production of cell suspensions |
| 09/08/2004 | EP1453929A1 Film structures and methods of making film structures |
| 09/08/2004 | EP1453916A2 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof |
| 09/08/2004 | EP1453909A1 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 09/08/2004 | EP1453855A1 Antimicrobial bolisin peptides |
| 09/08/2004 | EP1453845A2 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same |